Cytomedix, Inc. announced the appointment of Dean Tozer as its Executive Vice President and Chief Commercial Officer. Mr. Tozer will be in charge of all commercial activity for AutoloGel and will lead the effort to drive product adoption in the estimated $3.4 billion U.S. wound care market. The company also announced the appointment of Jennifer Linsky as its Senior Director of National Accounts.

Dean Tozer has more than 25 years' experience in the global healthcare industry and has an established track record of successfully launching and marketing wound care products. Jennifer Linsky also joins Cytomedix from Shire Regenerative Medicine, where she was a National Accounts Manager and National Manager of Market and Business Development. At Shire, she launched a business development and comprehensive disease management program initiative that increased the diabetic wound market potential nationwide.